Movement Disorder Unit, Neurological Service, Carlos Andrade Marín Hospital, Quito, Ecuador.
Mov Disord. 2010 Oct 15;25(13):2121-7. doi: 10.1002/mds.23152.
The RSGE-PD-V2.0 is a specific measure for evaluation of gait impairment in PD.
To check the RSGE-PD-V2.0 metrics attributes.
In addition to demographic and historical data of PD, applied assessments were: Hoehn and Yahr staging (H&Y); impact in daily activities with Schwab and England scale (S&E); SCOPA Motor; mental status with Short portable mental status questionnaire (SPMSQ); quality of life with Parkinson's impact scale (PIMS), the Hamilton Depression Rating Scale-6 items (HDRS-6); and, the Clinical Impression of Severity Index-PD (CISI-PD).
151 PD patients were included (n = 102 (67.5%) were male). Most patients were in H&Y stage 3 (n = 78 (51.6%)). Mean of age and duration of disease was 68.4 and 7.6 years respectively. Mean values of L-Dopa doses was 652.6 mg/day. Mean values of SCOPA Motor were 29.1; SPMSQ: 1.8; HADS-6: 9.2; PIMS: 18.7;RSGE-PD-V2.0: 25.4; and, CISI-PD were 10.8. Full computable scores were 100%; Guttman's lambda, 0.954; and the item-total correlation, 0.408-0.830. Correlation coefficients (Spearman's rho) between RSGE-PD-V2.0 and H&Y, S&E, SCOPA Motor, PIMS and CISI-PD, were: 0.62; -0.75; 0.74; 0.46; and, 0.78 respectively. RSGE-PD-V2.0 scale significantly discriminated among PD severity levels (based on H&Y staging) Kruskal-Wallis (p < 0.000).
Metric attributes of the RSGE-PD-V2.0 in this sample of study resulted in has sufficient and suitable satisfactory. We, therefore, believe that RSGE-PD-V2.0 is easy and a useful and recommendable specific tool for measuring gait disease in PD patients.
RSGE-PD-V2.0 是评估 PD 患者步态障碍的特定工具。
检查 RSGE-PD-V2.0 指标属性。
除了 PD 的人口统计学和历史数据外，还应用了以下评估方法：Hoehn 和 Yahr 分期（H&Y）； Schwab 和 England 量表（S&E）评估日常生活活动的影响；SCOPA 运动评分；简易精神状态检查（SPMSQ）评估精神状态；帕金森病影响量表（PIMS）评估生活质量；汉密尔顿抑郁量表-6 项（HDRS-6）；临床疾病严重程度印象指数-PD（CISI-PD）。
共纳入 151 例 PD 患者（n=102，67.5%为男性）。大多数患者处于 H&Y 分期 3 期（n=78，51.6%）。平均年龄和病程分别为 68.4 岁和 7.6 年。平均左旋多巴剂量为 652.6mg/天。SCOPA 运动评分为 29.1；SPMSQ 为 1.8；HADS-6 为 9.2；PIMS 为 18.7；RSGE-PD-V2.0 为 25.4；CISI-PD 为 10.8。完整可计算分数为 100%；Guttman 氏 lambda 值为 0.954；项目总分相关系数为 0.408-0.830。RSGE-PD-V2.0 与 H&Y、S&E、SCOPA 运动评分、PIMS 和 CISI-PD 的相关性系数（Spearman rho）分别为 0.62、-0.75、0.74、0.46 和 0.78。RSGE-PD-V2.0 量表在基于 H&Y 分期的 PD 严重程度分级中具有显著的区分度（Kruskal-Wallis，p<0.000）。
在本研究样本中，RSGE-PD-V2.0 的度量属性具有足够且令人满意的可靠性。因此，我们认为 RSGE-PD-V2.0 是一种简单、有用和推荐的 PD 患者步态疾病测量工具。
